Cue Biopharma, Inc. (CUE) stock
CUENasdaqPharmaceutical PreparationsFiscal year ends December 31
$17.50−1.16 (-6.22%)
Close on Nov 12, 2026Market cap $127.13MP/E –Yield –
Cue Biopharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cue Biopharma's enterprise value was $80.19M on Nov 11, 2026, against $30.34M a year earlier. Over the last 5 years it ranged from -$4.92M to $287.11M, with a median of $52.85M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $80.19M | +1477.0% |
| 2025 | Dec 31, 2025 | $5.08M | -86.8% |
| 2024 | Dec 31, 2024 | $38.54M | -47.6% |
| 2023 | Dec 29, 2023 | $73.61M | +42.4% |
| 2022 | Dec 30, 2022 | $51.71M | -82.0% |
| 2021 | Dec 31, 2021 | $287.11M | +0.2% |
| 2020 | Dec 31, 2020 | $286.68M | -14.0% |
| 2019 | Dec 31, 2019 | $333.31M | +501.0% |
| 2018 | Dec 31, 2018 | $55.45M | – |
See a number that looks wrong?